PHP
TNGX icon

Parkman Healthcare Partners’s Tango Therapeutics TNGX Stock Holding History

Parkman Healthcare Partners’s Portfolio TNGX Stock Details TNGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$5.57M Buy
+266,127
New +$3.7M 0.57% 52
2024
Q1 		– Sell
-65,679
Closed -$650K – 114
2023
Q4 		$650K Sell
65,679
-70,241
-52% -$610K 0.09% 85
2023
Q3 		$1.53M Buy
+135,920
New +$829K 0.28% 84

Other funds holding TNGX

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
BCM
Boxer Capital Management San Diego, California $762M AUM 1,125.36% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
TGI
TRV GP IV Boston, Massachusetts $267M AUM 965.83% 1-Year Est. Return

Parkman Healthcare Partners's TNGX Position: Q1 2026 in Review

Parkman Healthcare Partners opened a new position in Tango Therapeutics (TNGX) in Q1 2026: 266,127 shares worth $5.57M. The stake represents 0.57% of the portfolio and ranks #52 among its holdings. This is a return to the name: Parkman Healthcare Partners previously reported a position in TNGX as recently as Q4 2023.

Parkman Healthcare Partners first reported a position in TNGX in Q3 2023 and has held it in 3 quarters since. 194 funds tracked by Wall St. Rank hold TNGX as of Q1 2026.

  • Parkman Healthcare Partners held 266,127 shares of Tango Therapeutics worth $5.57M as of Q1 2026.
  • Tango Therapeutics was a new Parkman Healthcare Partners position in Q1 2026.
  • Tango Therapeutics made up 0.57% of Parkman Healthcare Partners's portfolio in Q1 2026, its #52 holding.
  • Parkman Healthcare Partners first reported a position in Tango Therapeutics in Q3 2023 and has held it in 3 quarters since.
  • 194 funds tracked by Wall St. Rank held Tango Therapeutics as of Q1 2026.

Based on Parkman Healthcare Partners's 13F filing for Q1 2026, filed 15 May 2026.